| Ident. | Authors (with country if any) | Title |
|---|
| 000042 |
Atheendar S. Venkataramani [États-Unis] ; Harsha Thirumurthy [États-Unis] ; Jessica E. Haberer [États-Unis] ; Yap Ii Boum [Ouganda] ; Mark J. Siedner [États-Unis] ; Annet Kembabazi [Ouganda] ; Peter W. Hunt [États-Unis] ; Jeffrey N. Martin [États-Unis] ; David R. Bangsberg [États-Unis, Ouganda] ; Alexander C. Tsai [États-Unis] | CD4+ cell count at antiretroviral therapy initiation and economic restoration in rural Uganda |
| 000063 |
John R. Koethe [Zambie, États-Unis] ; Meridith Blevins [États-Unis] ; Claire Bosire [États-Unis] ; Christopher Nyirenda [Zambie] ; Edmond K. Kabagambe [États-Unis] ; Albert Mwango [États-Unis, Zambie] ; Webster Kasongo [États-Unis, Zambie] ; Isaac Zulu [Zambie] ; Bryan E. Shepherd [États-Unis] ; Douglas C. Heimburger [Zambie, États-Unis] | Self-reported dietary intake and appetite predict early treatment outcome among low-BMI adults initiating HIV treatment in sub-Saharan Africa |
| 000076 |
Alexander J. Stockdale [Royaume-Uni] ; Joseph Nkuranga [Kenya] ; M. Estee Örök [Royaume-Uni] ; Brian Faragher [Royaume-Uni] ; David G. Lalloo [Royaume-Uni] | Initiation of antiretroviral therapy in HIV-infected tuberculosis patients in rural Kenya: an observational study |
| 000098 |
Pauli N. Amornkul [États-Unis] ; Etienne Karita [Rwanda] ; Anatoli Kamali [Ouganda] ; Wasima N. Rida [États-Unis] ; Eduard J. Sanders [Kenya, Royaume-Uni] ; Shabir Lakhi [Zambie] ; Matt A. Price [États-Unis] ; William Kilembe [Zambie] ; Emmanuel Cormier [États-Unis] ; Omu Anzala [Kenya] ; Mary H. Latka [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Susan A. Allen [Rwanda, Zambie, États-Unis] ; Jill Gilmour [Royaume-Uni] ; Patricia E. Fast [États-Unis] | Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa |
| 000117 |
Edward J. Mills [Canada] ; Celestin Bakanda [Ouganda] ; Josephine Birungi [Ouganda] ; Sanni Yaya [Canada] ; Nathan Ford [Suisse] | The prognostic value of baseline CD4+ cell count beyond 6 months of antiretroviral therapy in HIV-positive patients in a resource-limited setting |
| 000138 |
Kwamena William Coleman Sagoe [Ghana] ; Afrakoma Adjoa Agyei [Ghana] ; Francesca Ziga [Ghana] ; Margaret Lartey [Ghana] ; Theophilus K. Adiku [Ghana] ; Makafui Seshi Max Q. Arens [États-Unis] ; Julius Abraham Addo Mingle [Ghana] | Prevalence and Impact of Hepatitis B and C Virus Co-Infections in Antiretroviral Treatment Naive Patients With HIV Infection at a Major Treatment Center in Ghana |
| 000185 |
Charlotte Lewden [France] ; Delphine Gabillard [France] ; Albert Minga [France, Côte d'Ivoire] ; Didier K. Ekouevi [France, Côte d'Ivoire] ; Divine Avit [Côte d'Ivoire] ; Issouf Konate [Burkina Faso] ; Clarisse Amani-Bosse [Côte d'Ivoire] ; Eugène Messou [Côte d'Ivoire] ; Patrick Coffie [France, Côte d'Ivoire] ; Abdoulaye Ouedraogo [Burkina Faso] ; Christian Laurent [France] ; Xavier Anglaret [France, Côte d'Ivoire] | CD4-Specific Mortality Rates Among HIV-Infected Adults With High CD4 Counts and No Antiretroviral Treatment in West Africa |
| 000188 |
S. Takuva [Arabie saoudite, Afrique du Sud] ; D. Westreich [États-Unis] ; C. N. Menezes [Afrique du Sud] ; L. Mcnamara [Arabie saoudite] ; I. Sanne [Arabie saoudite, Afrique du Sud] ; L. Page-Shipp [Afrique du Sud] ; M. Maskew [Arabie saoudite] | Antiretroviral therapy initiation during tuberculosis treatment and HIV-RNA and CD4 T-lymphocyte responses |
| 000215 |
Denis Nash [États-Unis] ; YINGFENG WU [États-Unis] ; Batya Elul [États-Unis] ; David Hoos [États-Unis] ; Wafaa El Sadr [États-Unis] | Program-level and contextual-level determinants of low-median CD4+ cell count in cohorts of persons initiating ART in eight sub-Saharan African countries |
| 000222 |
L. Thairu [États-Unis] ; D. Katzenstein [États-Unis] ; D. Israelski [États-Unis] | Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa |
| 000233 |
Peter W. Hunt [États-Unis] ; Huyen L. Cao [États-Unis, Ouganda] ; Conrad Muzoora [Ouganda] ; Isaac Ssewanyana [Ouganda] ; John Bennett [États-Unis] ; Nneka Emenyonu [Ouganda, États-Unis] ; Annet Kembabazi [Ouganda] ; Torsten B. Neilands [États-Unis] ; David R. Bangsberg [Ouganda, États-Unis] ; Steven G. Deeks [États-Unis] ; Jeffrey N. Martin [États-Unis] | Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy |
| 000291 |
Stefaan F. Van Der Borght [Pays-Bas] ; Maarten F. Schim Van Der Loeff [Pays-Bas] ; Philippe Clevenbergh [Pays-Bas, France] ; Jean Pierre Kabarega [Rwanda] ; Emmanuel Kamo [Burundi] ; Katinka Van Cranenburgh [Pays-Bas] ; Henk Rijckborst [Pays-Bas] ; Joep M. Lange [Pays-Bas] ; Tobias F. Rinke De Wit [Pays-Bas] | Long-term voluntary counseling and testing (VCT) uptake dynamics in a multicountry HIV workplace program in sub-Saharan Africa |
| 000367 |
Pamela Fergusson [Royaume-Uni] ; Andrew Tomkins [Royaume-Uni] | HIV prevalence and mortality among children undergoing treatment for severe acute malnutrition in sub-Saharan Africa: a systematic review and meta-analysis |
| 000521 |
Louise Kuhn [États-Unis] ; Donald M. Thea [États-Unis] ; Grace M. Aldrovandi [États-Unis] ; Anirban Chatterjee [États-Unis] ; Ronald J. Bosch [États-Unis] ; David J. Hunter [États-Unis] ; Maulidi R. Fataki [Tanzanie] ; Gernard I. Msamanga [Tanzanie] ; Wafaie W. Fawzi [États-Unis] | Maternal Disease Stage and Child Undernutrition in Relation to Mortality Among Children Born to HIV-Infected Women in Tanzania. Commentary |
| 000537 |
Sylvie Deuffic-Burban [France] ; Elena Losina [États-Unis] ; BINGXIA WANG [États-Unis] ; Delphine Gabillard [France] ; Eugène Messou [Côte d'Ivoire] ; Nomita Divi [États-Unis] ; Kenneth A. Freedberg [États-Unis] ; Xavier Anglaret [France] ; Yazdan Yazdanpanah [France] | Estimates of opportunistic infection incidence or death within specific CD4 strata in HIV-infected patients in Abidjan, Côte d'Ivoire : impact of alternative methods of CD4 count modelling |
| 000549 |
Carolyn Bolton-Moore [Zambie] ; Mwangelwa Mubiana-Mbewe [Zambie] ; Ronald A. Cantrell [États-Unis] ; Namwinga Chintu [Zambie] ; Elizabeth M. Stringer [Zambie] ; Benjamin H. Chi [Zambie] ; Moses Sinkala [Zambie] ; Chipepo Kankasa [Zambie] ; Craig M. Wilson [États-Unis] ; Catherine M. Wilfert [États-Unis] ; Albert Mwango [Zambie] ; Jens Levy [Zambie] ; Elaine J. Abrams [États-Unis] ; Marc Bulterys [Zambie] ; Jeffrey S. A. Stringer [Zambie, États-Unis] | Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia |
| 000558 |
Gary M. Cohen [États-Unis] | Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in dedeveloping countries |
| 000585 |
Nohelly Nombela [France] ; Bertin Kouadio [Côte d'Ivoire] ; Siaka Toure [Côte d'Ivoire] ; Catherine Seyler [Côte d'Ivoire] ; Yves-Antoine Flori [France] ; Xavier Anglaret [France, Côte d'Ivoire] | Nonantiretroviral drug consumption by CD4 cell count in HIV-infected adults : A 5-year cohort study in Côte d'Ivoire |
| 000606 |
April A. Truett [États-Unis] ; Andrew Letizia [États-Unis] ; Evans Malyangu [Zambie] ; Frank Sinyangwe [Zambie] ; Brandi N. Morales [États-Unis] ; Nancy F. Crum [États-Unis] ; Suzanne M. Crowe [Australie] | Efficacy of cyto-chex blood preservative for delayed manual CD4 testing using dynal T4 quant CD4 test among HIV-infected persons in Zambia |
| 000628 |
Max Katubulushi [Zambie] ; Isaac Zulu [Zambie] ; Felistah Yavwa [Zambie] ; Paul Kelly [Zambie] | Slow decline in CD4 cell count in a cohort of HIV-infected adults living in Lusaka, Zambia |
| 000634 |
P. A. Venkatesh [États-Unis] ; R. J. Bosch [États-Unis] ; K. Mcintosh [États-Unis] ; F. Mugusi [Tanzanie] ; G. Msamanga [Tanzanie] ; W. W. Fawzi [États-Unis] | Predictors of incident tuberculosis among HIV-1-infected women in Tanzania |
| 000683 |
Motasim Badri [Afrique du Sud] ; Linda-Gail Bekker [Afrique du Sud] ; Catherine Orrell [Afrique du Sud] ; Jennifer Pitt [Afrique du Sud] ; Francois Cilliers [Afrique du Sud] ; Robin Wood [Afrique du Sud] | Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines |
| 000684 |
Marianne A. B. Van Der Sande [Gambie] ; Maarten F. Schim Van Der Loeff [Royaume-Uni] ; Rachel C. Bennett [Gambie] ; Mary Dowling [Gambie] ; Akum A. Aveika [Gambie] ; Toyin O. Togun [Gambie] ; Saihou Sabally [Gambie] ; David Jeffries [Gambie] ; Richard A. Adegbola [Gambie] ; Ramu Sarge-Njie [Gambie] ; Assan Jaye [Gambie] ; Tumani Corrah [Gambie] ; Samuel Mcconkey [Gambie] ; Hilton C. Whittle [Gambie] | Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2 |
| 000687 |
Dominique Bonard [Côte d'Ivoire] ; Eugène Messou [Côte d'Ivoire] ; Catherine Seyler [Côte d'Ivoire] ; Véronique Vincent [France] ; Delphine Gabillard [France] ; Xavier Anglaret [Côte d'Ivoire, France] | High incidence of atypical mycobacteriosis in African HIV-infected adults with low CD4 cell counts: a 6-year cohort study in Côte d'Ivoire |
| 000717 |
Cornelia Staehelin [Suisse] ; Martin Rickenbach [Suisse] ; Nicola Lows [Royaume-Uni] ; Martin Egger [Suisse] ; Bruno Ledergerber [Suisse] ; Bernard Hirschel [Suisse] ; Valérie D'Acremont [Suisse] ; Manuel Battegay [Suisse] ; Thomas Wagels [Suisse] ; Enos Bernasconi [Suisse] ; Christine Kopp [Suisse] ; Hansjakob Furrer [Suisse] ; Julia Del Amo [Espagne] ; Georg Bröring [Pays-Bas] ; Kevin Fenton [Royaume-Uni] | Migrants from Sub-Saharan Africa in the Swiss HIV Cohort Study: access to antiretroviral therapy, disease progression and survival. Commentary |
| 000724 |
E. Sandström [Suède] ; W. Urassa [Tanzanie] ; M. Bakari [Suède] ; A. Swai [Tanzanie] ; F. Mhalu [Tanzanie] ; G. Biberfeld [Suède] ; K. Pallangyo [Tanzanie] | Estimation of CD4 T-lymphocyte counts from percent CD4 T-lymphocyte determinations in HIV-1-infected subjects in sub-Saharan Africa |
| 000892 |
D. Morgan [Ouganda] ; A. Rutebemberwa [Ouganda] ; S. Malamba [Ouganda] ; A. Ross [Ouganda] ; J. Whitworth [Ouganda] ; P. Kaleebu [Ouganda] ; F. Gotch [Royaume-Uni] | HIV-1 RNA levels in an african population-based cohort and their relation to CD4 lymphocyte counts and World Health Organization clinical staging |
